Musculoskeletal chronic graft versus host disease – A rare complication of allogeneic hematopoietic stem cell transplantation: A case report and review of its literature

Vasu Babu Goli; Reetu Jain; Ganapathi Bhat; Anjana Sainani; S. H. Advani

doi:10.4103/sajc.sajc_145_17

South Asian Journal of Cancer, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · South Asian J Cancer 2017; 06(04): 150-168
DOI: 10.4103/sajc.sajc_145_17

Letter to the Editor

Musculoskeletal chronic graft versus host disease – A rare complication of allogeneic hematopoietic stem cell transplantation: A case report and review of its literature

Autor*innen

Vasu Babu Goli

Department of Medical Oncology and Bone Marrow Transplant, Jaslok Hospital, Mumbai, Maharashtra, India
Reetu Jain

Department of Medical Oncology and Bone Marrow Transplant, Jaslok Hospital, Mumbai, Maharashtra, India
Ganapathi Bhat

Department of Medical Oncology and Bone Marrow Transplant, Jaslok Hospital, Mumbai, Maharashtra, India
Anjana Sainani

Department of Medical Oncology and Bone Marrow Transplant, Jaslok Hospital, Mumbai, Maharashtra, India
S. H. Advani

Department of Medical Oncology and Bone Marrow Transplant, Jaslok Hospital, Mumbai, Maharashtra, India

Abstract

als PDF herunterladen

PDF (348 kb)

Referenzen

References
1 Oda K, Nakaseko C, Ozawa S, Nishimura M, Saito Y, Yoshiba F, et al. Fasciitis and myositis: An analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transplant 2009;43:159-67.
2 Openshaw H. Neurological manifestations of chronic graft versus hostdisease. In: Vogelsang GB, Pavletic SZ, editors. Chronic Graft Versuhost Disease. New York: Cambridge University Press; 2009. p. 243-51.
3 Duell T, van Lint MT, Ljungman P, Tichelli A, Socié G, Apperley JF, et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT working party on late effects and EULEP study group on late effects. European group for blood and marrow transplantation. Ann Intern Med 1997;126:184-92.
4 Min CK. The pathophysiology of chronic graft-versus-host disease: The unveiling of an enigma. Korean J Hematol 2011;46:80-7.
5 Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report. Biol Blood Marrow Transplant 2006;12:31-47.
6 Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
7 Grauer O, Wolff D, Bertz H, Greinix H, Kühl JS, Lawitschka A, et al. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: Report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Brain 2010;133:2852-65.